← Back to Search

Behavioural Intervention

Implementation Intervention for Tobacco Smoking (IMPACT Trial)

N/A
Waitlist Available
Led By Gail Daumit, MD, MHS
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 months
Awards & highlights

IMPACT Trial Summary

This trial will test whether a new intervention can help community mental health clinics deliver evidence-based smoking cessation treatment to patients.

IMPACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in provider knowledge of smoking cessation treatment as assessed by a 16-item scale
Smoke
Secondary outcome measures
Change in acceptability of evidence-based practices based on adaptation of Acceptability of Intervention Measure
Change in acceptability of implementation intervention based on adaptation of Acceptability of Intervention Measure
Change in appropriateness of evidence-based practices based on adaptation of the Intervention Appropriateness Measure
+7 more
Other outcome measures
Change in tobacco smoking abstinence

IMPACT Trial Design

1Treatment groups
Experimental Treatment
Group I: Implementation InterventionExperimental Treatment1 Intervention
All participants will receive the implementation intervention.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,820,689 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,784 Previous Clinical Trials
2,689,184 Total Patients Enrolled
Gail Daumit, MD, MHSPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

With what objectives is this experiment being conducted?

"The aim of this trial, assessed over a 12 months period from baseline, is to gauge the shift in healthcare providers' knowledge on smoking cessation treatment using a 16-item scale. Secondary objectives include gauging the acceptability and appropriateness of evidence based practices using an adapted Acceptability Of Intervention Measure (AIM) with 24 items scaling 1-5 and an adapted Intervention Appropriateness Measure (IAM) composed of 16 items also ranging from 1-5."

Answered by AI

Are patients currently being admitted to this investigation?

"It appears that, according to the clinicaltrials.gov database, this specific study is no longer recruiting participants. The trial was first launched on March 12th 2021 and has not been updated since March 30th 2022. Fortunately there are 42 other ongoing trials in search of patients right now."

Answered by AI
~22 spots leftby Apr 2025